13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001856083
申报总市值
US$68.7亿
US$68.7亿
63 檔
34.6%
截至 Q1 2026 季度末，Deep Track Capital, LP 的美股持仓估值约为 US$68.7亿，全数申报仓位共有 63 档。
在 Q1 2026，Deep Track Capital, LP 操作展现出积极扩展与加仓意向。本季共新建仓 16 个新仓位，并对 23 个既有持股进行加仓（合计增持 39 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Deep Track Capital, LP 的前 5 大核心持股（包含 XBI, GH, IMVT 等）合计占整体申报市值的 34.6%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 20.86% | -20.86% | EXIT | |
| 2 | GH | Guardant Health Inc | 股票-医疗保健 | 5.04% | +2.37% | +19.22% | |
| 3 | IMVT | Immunovant Inc | 股票-其他 | 4.68% | +0.56% | — | |
| 4 | TARS | Tarsus Pharmaceuticals Inc | 股票-其他 | 4.12% | -0.76% | +19.84% | |
| 5 | PCVX | Vaxcyte Inc | 股票-其他 | 4.08% | -0.44% | +7.50% | |
| 6 | GPCR | Structure Therapeutics Inc | 股票-其他 | 3.37% | +0.33% | +4.09% | |
| 7 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 3.04% | -0.55% | -4.35% | |
| 8 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 2.98% | -2.98% | EXIT | |
| 9 | OCUL | Ocular Therapeutix Inc | 股票-其他 | 2.72% | +0.09% | +143.93% | |
| 10 | VERA | Vera Therapeutics Inc | 股票-其他 | 2.70% | -0.20% | +45.55% | |
| 11 | ALMS | Alumis Inc | 股票-其他 | 2.44% | +0.16% | — | |
| 12 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 2.39% | +0.15% | +14.71% | |
| 13 | NUVL | Nuvalent Inc-a | 股票-其他 | 2.30% | +0.91% | — | |
| 14 | ALKS | Alkermes plc | 股票-医疗保健 | 2.07% | +0.98% | +79.52% | |
| 15 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 2.05% | -2.05% | EXIT | |
| 16 | MLTX | Moonlake Immunotherapeutics | 股票-其他 | 1.95% | +0.03% | +39.02% | |
| 17 | MAZE | Maze Therapeutics Inc | 股票-其他 | 1.70% | -0.08% | -18.11% | |
| 18 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 1.63% | +1.04% | -5.89% | |
| 19 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 1.61% | +1.12% | -9.82% | |
| 20 | GMAB | Genmab A/s -sp Adr | 股票-其他 | 1.61% | +1.86% | — | |
| 21 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 1.48% | -0.61% | -58.82% | |
| 22 | GRAL | Grail Inc | 股票-医疗保健 | 1.45% | +0.37% | +68.44% | |
| 23 | LBRX | Lb Pharmaceuticals Inc | 股票-其他 | 1.35% | +0.23% | — | |
| 24 | MBX | Mbx Biosciences Inc | 股票-其他 | 1.34% | +0.05% | -15.15% | |
| 25 | BCAX | Bicara Therapeutics Inc | 股票-其他 | 1.32% | +0.45% | +55.41% | |
| 26 | CMPS | Compass Pathways PLC | 股票-其他 | 1.10% | +1.40% | +65.82% | |
| 27 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 1.06% | +1.69% | -50.00% | |
| 28 | BBIO | Bridgebio Pharma Inc | 股票-医疗保健 | 1.02% | -1.02% | EXIT | |
| 29 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 0.95% | -0.81% | -3.60% | |
| 30 | TNGX | Tango Therapeutics Inc | 股票-其他 | 0.94% | +0.97% | +12.04% | |
| 31 | DFTX | Definium Therapeutics Inc | 股票-其他 | 0.93% | +0.95% | — | |
| 32 | 430 | Terns Pharmaceuticals Inc | 股票-其他 | 0.92% | -0.92% | EXIT | |
| 33 | GERN | Geron CORP | 股票-其他 | 0.77% | -0.77% | EXIT | |
| 34 | ANIP | Ani Pharmaceuticals Inc | 股票-其他 | 0.75% | -0.75% | EXIT | |
| 35 | CRMD | Cormedix Inc | 股票-其他 | 0.70% | +0.02% | +18.96% | |
| 36 | ATAI | Ataibeckley Inc | 股票-其他 | 0.69% | +0.42% | — | |
| 37 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 0.67% | +0.92% | -32.45% | |
| 38 | COGT | Cogent Biosciences Inc | 股票-其他 | 0.63% | +0.50% | +120.70% | |
| 39 | CRVS | Corvus Pharmaceuticals Inc | 股票-其他 | 0.60% | -0.06% | — | |
| 40 | DYN | Dyne Therapeutics Inc | 股票-其他 | 0.59% | -0.11% | -24.53% | |
| 41 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 0.59% | -0.59% | EXIT | |
| 42 | ACRS | Aclaris Therapeutics Inc | 股票-其他 | 0.57% | +0.15% | — | |
| 43 | MANE | Veradermics Inc | 股票-其他 | 0.52% | +3.06% | — | |
| 44 | VSTM | Verastem Inc | 股票-其他 | 0.50% | -0.18% | — | |
| 45 | ✓ | Engene Holdings Inc | 股票-其他 | 0.49% | -0.49% | EXIT | |
| 46 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 0.45% | +0.51% | -44.79% | |
| 47 | XFOR | X4 Pharmaceuticals Inc | 股票-其他 | 0.43% | -0.03% | +26.45% | |
| 48 | SLDB | Solid Biosciences Inc | 股票-其他 | 0.42% | +0.10% | — | |
| 49 | ENTA | Enanta Pharmaceuticals Inc | 股票-其他 | 0.40% | -0.09% | — | |
| 50 | APGE | Apogee Therapeutics Inc | 股票-其他 | 0.39% | -0.39% | EXIT |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | 260 | Centessa Pharmaceuticals-adr | +1.2% | +57.90% | 加仓 |
| 2 | ALKS | Alkermes plc | +1.1% | +79.52% | 加仓 |
| 3 | OCUL | Ocular Therapeutix Inc | +1% | +143.93% | 加仓 |
| 4 | MLTX | Moonlake Immunotherapeutics | +0.9% | +39.02% | 加仓 |
| 5 | PCVX | Vaxcyte Inc | +0.8% | +7.50% | 加仓 |
| 6 | TNGX | Tango Therapeutics Inc | +0.6% | +12.04% | 加仓 |
| 7 | BCAX | Bicara Therapeutics Inc | +0.5% | +55.41% | 加仓 |
| 8 | ORKA | Oruka Therapeutics Inc | +0.5% | -5.89% | 减仓 |
| 9 | 430 | Terns Pharmaceuticals Inc | +0.4% | +39.64% | 加仓 |
| 10 | COGT | Cogent Biosciences Inc | +0.3% | +120.70% | 加仓 |
| 11 | JANX | Janux Therapeutics Inc | +0.3% | +1225.26% | 加仓 |
| 12 | CMPS | Compass Pathways PLC | +0.2% | +65.82% | 加仓 |
| 13 | VERA | Vera Therapeutics Inc | +0.2% | +45.55% | 加仓 |
| 14 | CNTX | Context Therapeutics Inc | +0.1% | — | 不变 |
| 15 | ANIP | Ani Pharmaceuticals Inc | +0.1% | +25.61% | 加仓 |
| 16 | XFOR | X4 Pharmaceuticals Inc | +0.1% | +26.45% | 加仓 |
| 17 | IVA | Inventiva SA - Adr | +0.1% | +149.48% | 加仓 |
| 18 | ✓ | Crescent Biopharma Inc. | 0% | — | 不变 |
| 19 | LBRX | Lb Pharmaceuticals Inc | 0% | — | 不变 |
| 20 | GERN | Geron CORP | — | -2.43% | 减仓 |
| 21 | IONS | Ionis Pharmaceuticals Inc | 0% | +14.71% | 加仓 |
| 22 | BLLN | Billiontoone Inc Cl A | 0% | — | 不变 |
| 23 | ALGS | Aligos Therapeutics Inc | 0% | — | 不变 |
| 24 | GH | Guardant Health Inc | -0.1% | +19.22% | 加仓 |
| 25 | BBIO | Bridgebio Pharma Inc | -0.1% | +3.86% | 加仓 |
| 26 | GRAL | Grail Inc | -0.1% | +68.44% | 加仓 |
| 27 | ENTA | Enanta Pharmaceuticals Inc | -0.2% | — | 不变 |
| 28 | HELP | Cybin Inc | -0.2% | -29.18% | 减仓 |
| 29 | ✓ | Engene Holdings Inc | -0.2% | — | 不变 |
| 30 | SLNOEUR | Soleno Therapeutics Inc | -0.2% | +7.87% | 加仓 |
| 31 | CLDX | Celldex Therapeutics Inc | -0.3% | -32.45% | 减仓 |
| 32 | TARS | Tarsus Pharmaceuticals Inc | -0.3% | +19.84% | 加仓 |
| 33 | VSTM | Verastem Inc | -0.3% | — | 不变 |
| 34 | IMCR | Immunocore Holdings Plc-adr | -0.3% | -3.60% | 减仓 |
| 35 | DYN | Dyne Therapeutics Inc | -0.3% | -24.53% | 减仓 |
| 36 | CRMD | Cormedix Inc | -0.4% | +18.96% | 加仓 |
| 37 | MBX | Mbx Biosciences Inc | -0.5% | -15.15% | 减仓 |
| 38 | APLSUSD | Apellis Pharmaceuticals Inc | -0.5% | -41.52% | 减仓 |
| 39 | IMVT | Immunovant Inc | -0.5% | — | 不变 |
| 40 | AXSM | Axsome Therapeutics Inc | -0.7% | -4.35% | 减仓 |
| 41 | NRIX | Nurix Therapeutics Inc | -0.8% | -9.82% | 减仓 |
| 42 | XBI | Ss Spdr S&p Biotech ETF | -0.9% | — | 不变 |
| 43 | VRDN | Viridian Therapeutics Inc | -1% | -44.79% | 减仓 |
| 44 | BMRN | Biomarin Pharmaceutical Inc | -1.4% | -50.00% | 减仓 |
| 45 | MAZE | Maze Therapeutics Inc | -1.4% | -18.11% | 减仓 |
| 46 | GPCR | Structure Therapeutics Inc | -1.7% | +4.09% | 加仓 |
| 47 | CYTK | Cytokinetics Inc | -2.3% | -58.82% | 减仓 |
| 48 | DVAX | Dynavax Technologies CORP | — | EXIT | 清仓 |
| 49 | ALMS | Alumis Inc | — | NEW | 新建仓 |
| 50 | NUVL | Nuvalent Inc-a | — | NEW | 新建仓 |
根据 SEC 官方 Form 13F 申报备案，Deep Track Capital, LP 在 Q1 2026 季度的美股持仓总市值约为 US$68.7亿，共申报了 63 个公开持股仓位。
在 Q1 2026 季度，Deep Track Capital, LP 按市值排列的前三大核心持股分别为：XBI (20.9%)、GH (5.0%)、IMVT (4.7%)。其中最大持股仓位 XBI 占据整体投资组合约 20.9% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
ALMS
市值: US$1.5亿
本季最大获利了结 / 清仓标的
DVAX
前期市值: US$2.4亿
在 Q1 2026 季度中，Deep Track Capital, LP 共进行了 61 项持仓异动，包含新建仓 16 个仓位、加仓 23 个仓位、减仓 14 个仓位以及清仓 8 个仓位。 其中最大新建仓标的为 ALMS。 本季清仓仓位包含 DVAX。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。